Philadelphia Cardiovascular Congress
The Philadelphia Cardiovascular Congress is a comprehensive one and a half day program on the latest trends in the medical and surgical management of cardiovascular diseases. Faculty presentations will feature leaders in the fields of cardiology, cardiothoracic surgery, vascular surgery, and vascular medicine.
Topics will cover the following areas:
- Aortic Valve
- Mitral Valve
- Heart Failure
- Coronary Artery Disease
- Case Presentations
- Informative Debates
Introducing an Advanced Nurse Practitioner Track on Day 1! Nursing pharmacology credits offered.
To successfully complete this activity, the required evaluation must be completed no later than Monday, December 20, 2021. Thereafter, the evaluation will no longer be available and credits will not be issued. No refunds will be offered for failure to complete the required evaluation by the stated deadline.
This course is designed for all specialists and healthcare professionals working in cardiology, surgery, and primary care.
After completing this educational activity, learners will be able to:
- Employ echocardiography to identify patients with severe aortic stenosis and regurgitation.
- Discuss potential treatment options depending on the etiology of the valvar problem and other patient factors that may determine TAVR vs. SAVR.
- Interpret the echocardiography of significant mitral valve and tricuspid valve evaluation.
- Examine the timing and options for treating mitral regurgitation, tricuspid regurgitation, and atrial fibrillation.
- Recognize the impact of untreated atrial fibrillation in the mortality of aortic, mitral, and coronary surgeries.
- Recognize signs and symptoms of an acute aortic emergency.
- Identify an aortic aneurysm on CT scan and know size guidelines for surgical repair.
- Appraise options for ascending, aortic arch, thoracoabdominal, and abdominal aortic aneurysm repair.
- Differentiate the various types of heart failure.
- Select appropriate heart failure management option.
- Discuss advances in invasive monitoring and management options to provide the best long-term outcomes for patients.
- Discriminate between the various techniques available for treating coronary artery disease in order to best guide patients.
This preliminary agenda is subject to change, which may alter the credit count offered.
Find a convenient spot for any vehicle under 6’0” in the PARKWAY Bellevue Garage, which connects to The Bellevue Hotel via skybridge.
Parking rates for attendees is as follows (as of 1/6/20 - subject to change). See registration staff, onsite, for discount:
Event Day ONLY
A limited block of guest rooms at a special group rate have been reserved for attendees of the program as follows:
- Room Rates: Single & Double Occupancy - $209.00 plus applicable taxes, applicable service fees, and/or Hotel-specific fees in effect at the time of the Event.
To book your room please visit: https://www.hyatt.com/en-US/group-booking/PHLPH/G-11TJ
Featured Keynote Speaker
Stephen K. Klasko, MD, MBA
President, Thomas Jefferson University
CEO, Jefferson Health
Dr. Stephen Klasko is a transformative leader and advocate for a revolution in our systems of healthcare and higher education. In 2020 he published, UnHealthcare: A Manifesto for Health Assurance – in which he and Silicon Valley’s Hemant Taneja describe a new future for health care focused on keeping people well.
To read more about Dr. Klasko, click here.
Conflict of Interest
Thomas Jefferson University endorses the ACCME Standards for Commercial Support: Standards to Ensure Independence in CME Activities and the policies that supplement the Standards. All planners, faculty, authors, presenters, and content reviewers are required to disclose any relevant financial relationships with ACCME defined commercial interest entities within the past 12 months. Any conflict of interests have been resolved prior to this educational activity.
Such disclosures will be available prior to the start of the activity. Jefferson Conflict of Interest resolution process may result in changes to the program agenda.
No member of the planning committee have any relevant financial relationships to disclose.
Konstadinos Plestis, MD-Activity Director
Rohinton Morris, MD
Paul Dimuzio, MD
Rene Alvarez, MD
Richard Slobodien, MD
Jacqueline McGee, NP
Alice Isidro, PA
To view a list of faculty, click here.
Presenters are required to disclose at the start of their session if their content contains information of commercial products/devices that are unlabeled for use or investigational uses of products not yet approved.
The views expressed in this activity are those of the faculty. It should not be inferred or assumed that they are expressing the views of any manufacturer of pharmaceuticals or devices or Thomas Jefferson University.
It should be noted that the recommendations made herein with regard to the use of therapeutic agents, varying disease states, and assessments of risk, are based upon a combination of clinical trials, current guidelines, and the clinical practice experience of the participating presenters. The drug selection and dosage information presented in this activity are believed to be accurate. However, participants are urged to consult all available data on products and procedures before using them in clinical practice.
In support of improving patient care, Thomas Jefferson University is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians: This educational activity is designated for a maximum of 13.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses: This activity awards 13.25 nursing contact hours.
Thomas Jefferson University has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 13.25 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Other Healthcare Professionals: This educational activity is designated for 13.25 AMA PRA Category 1 Credits™. Participants should claim only the credit commensurate with the extent of their participation in the activity.
PA Patient Safety and Risk: The content for this activity qualifies for 2.5 PA Patient Safety and Risk credits.
The European Society of Cardiology and American College of Cardiology/American Heart Association Aortic Valve Practice Guidelines: What has changed and what you need to know
Impact of COVID on Cardiovascular Medical and Surgical Care
Impact of COVID on Cerebrovascular Disease
Debate SAVR vs TAVR in low risk patients: Do we have enough date to make a decision?
Nursing pharmacology: The educational activity offers 1.10 nursing pharmacotherapeutic credits.
Updates in the Diagnosis and Management of Thoracic Aortic Disease
Medical management of CAD
Outpatient LVAD Management
- 13.25 AMA PRA Category 1 Credit™
- 13.25 Attendance
- 13.25 CNE
- 1.10 CNE Pharmacotherapy
- 13.25 PA
- 2.50 Patient Safety
Early Bird Registration Rate
(on or before Sept. 6, 2021)
(after Sept. 6, 2021)
|Other Health Professional/ Retirees||$150||$185|
|Residents and Fellows (Non-Jefferson)||$150|
|Jefferson Health - Physician||$150|
|Jefferson Health - Other Healthcare Professional||$100|
|Jefferson Health - Residents and Fellows||$50|
|HOW TO REGISTER|
To register online, you must have a CPD @ JeffLearn account.
Recording and Photography Strictly Prohibited
Unauthorized recording or photography at a Jefferson-sponsored event is strictly prohibited. Individuals found violating this policy will be removed from the online activity or asked to leave from the live activity. No credits or refund will be issued.